Telmisartan

Drug Usage Statistics, United States, 2008 - 2018

Telmisartan Summary for 2018

Top drug rank #292 ( 43)
Estimated number of prescriptions in the United States (2018) 1,295,783
Estimated number of patients in the United States (2018) 325,634
 
Average total drug cost (USD)  
Per prescription $168.72
Per day of therapy $2.98/day
Average out-of-pocket cost (USD)  
Per prescription $19.68
Per day of therapy $0.42/day

Total Prescriptions and Patients Per Year (2008 - 2018)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 212  6
2009 238  26
2010 238 0
2011 223  15
2012 255  32
2013 280  25
Year Rank Change
2014 306  26
2015 307  1
2016 246  61
2017 249  3
2018 292  43

Drug Cost Over Time (2008 - 2018)

  • Cost Per Prescription Fill: Average cost per filled prescription regardless of how many days of therapy the prescription is filled for (e.g. 10 days, 30 days, 90 days, etc.)
  • Cost per Day of Therapy: The average cost per prescription fill divided by the days of therapy. For example, a 10-day antibiotic course costing $30 would be $3 per day. Similarly, a 30-day supply of an oral antihypetensive costing $30 would be $1 per day.

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Cost Per Prescription Fill (USD)

Cost Per Day of Therapy (USD/day)

NADAC (National Average Drug Acquisition Cost)

NADAC is the approximate cost of a medication that pharmacies (not patients) pay for a medication in the United States. Cost data is obtained via monthly surveys of community pharmacies. NADAC pricing is considered a more accurate alternative than average wholesale price (AWP). For more information, see NADAC (from Data.Medicaid.gov) or the NADAC data explorer.

NADAC prices vary by NDC (national drug code number), manufacturer, quanity of medication per bottle, and many other factors. The cost data displayed below represents the average pharmacy acquisition cost over the past 90 days.

Description Avg NADAC Price Pricing Unit

Distribution of Dispensed Dosage Forms (2018)

Dosage Form Strength % of Dispensed Products
Tablet/capsule 80 mg 58.8%
Tablet/capsule 40 mg 37.2%
Other, unspecified, or misc. 4.0%

Distribution of Days Supplied (2018)

"Days supply" is defined as the number of days that a prescription should last. For example, a prescription of 60 tablets that is taken twice daily has a day supply of 30 days.

Related Drugs

Drug Name Total Prescriptions (2018)
Losartan Potassium 50,479,750
Hydrochlorothiazide; Losartan Potassium 13,880,262
Valsartan 7,694,037
Irbesartan 3,490,431
Hydrochlorothiazide; Valsartan 3,261,560
Olmesartan Medoxomil 2,068,392
Telmisartan (this drug) 1,295,783
Sacubitril; Valsartan 1,249,669

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Micardis
Generic Drug Synonyms and Salts
  • Telmisartan

FDA Approval Information

Established Pharmacologic Class (EPC): Angiotensin 2 Receptor Blocker
Initial FDA approval date: 11/10/1998
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.2. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

RxHero - Gamified learning for the Top 250 Drugs
 
©2021 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 3, 2021
Back to Top
Top